Clinical Trial Supply Exclusive Survey Results Unveiled

915 views

Published on

Pharma IQ’s Clinical Trial Supply survey delved into ten key areas such as these to find out more about the main challenges you face. Don't miss a chance to learn what the consensus of your industry is in these survey findings. Download the full results below...some were surprising, but you spoke and we listened!

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
915
On SlideShare
0
From Embeds
0
Number of Embeds
6
Actions
Shares
0
Downloads
19
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Clinical Trial Supply Exclusive Survey Results Unveiled

  1. 1. Pharma IQ’s Clinical Trial Supply Europe Survey Results www.clinicalsupplyeurope.com This survey was conducted with key members of the Clinical Trial Supply area to gain an insight into how professionals are investing in Clinical Trial Supply, the regions they are operating in and their top priorities for 2010-11.
  2. 2. How many years have you been working in the Clinical T rial Supplies area? 19% 33%24% 24% 1-5 6-10 11 -15 16+ www.clinicalsupplyeurope.com
  3. 3. What is your number 1 priority area for 2011? 5% 63% 9% 18% 5% Cost cutting Overage cuts Supporting numerous new trials Supporting current trials Working specifically for trials in emerging markets Other (providing excellent customer service) www.clinicalsupplyeurope.com
  4. 4. Which areas are you looking to invest in for 2011? 24% 24% 19% 43% 5% 33% 14% 0% 10% 20% 30% 40% 50% Packagingandlabelling technologies/outsourcing Supplynetworkfornew clinicaltrial/s Comparatortrials Coolchaintechnologies Greenersupplychain Supplychainsin emergingmarkets Other(pleasespecify) Other areas include investing in Asia, forecasting systems and all of the above. N.B. Participants chose multiple options www.clinicalsupplyeurope.com
  5. 5. Approximately how many active trials does your company run a year? 10% 10% 24% 56% 1-10 11-20 21-30 31-40 41-50 50+ www.clinicalsupplyeurope.com
  6. 6. Of these, how many of these will be in BRIC countries in 2011? 19% 38% 14% 29% 5 or less 6-10 11-15 16+ www.clinicalsupplyeurope.com
  7. 7. Which areas are proving to be the most difficult to ship to? 52% 5% 29% 14% 10% 0% 10% 20% 30% 40% 50% 60% Russia and the Ukraine India China Latin America Other (please specify) www.clinicalsupplyeurope.com
  8. 8. Which aspects of the Clinical T rial Supply function in your company is outsourced? 29% 43% 24% 48% 29% 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% Manufacture Packaging and labelling Logistics Distribution Other (please specify) Other: Depot services, part of co-ordination, IVRS and all of the above N.B. Participants chose multiple options www.clinicalsupplyeurope.com
  9. 9. How many 3rd party partners do you work with in the CT S space? 47% 29% 5% 19% 5 or less 6-10 11-15 16+ www.clinicalsupplyeurope.com
  10. 10. What is your primary motivation for outsourcing? 14% 53% 33% Cost cutting Lack of internal experience/capabilities Other (please specify) Other: Lack of local presence in other continents, lack of resource flexibility and under developed IVRS technology. www.clinicalsupplyeurope.com
  11. 11. www.clinicalsupplyeurope.com Clinical Trial Supply Europe Dates: 26 - 28 January, 2011 Venue: World Trade Centre, Rotterdam, The Netherlands Innovative techniques for effective clinical supply planning, packaging and distribution to cut costs and speed time to market In response to industry demand, Pharma IQ’s Clinical Trial Supply Europe conference will bring together senior industry experts from across the globe to discuss innovative approaches to planning, packaging, distribution, comparator sourcing and much more in three days of interactive presentations and discussions. The 30 Clinical Trial experts will be sharing their expertise on: •Maintaining compliance with the evolving GxP regulatory landscape •Ensuring product viability of temperature controlled clinical materials •Guaranteeing uninterrupted supply in emerging markets such as Eastern Europe and Latin America PLUS! Don't miss: 1. 8+ hours of dedicated networking including an Evening Drinks Reception and Gala Dinner 2. Two tailored streams 3. Exclusive to Pharma IQ: Interactive Crisis Management Session For more information or to register: Tel: +44 207 368 9300 Email: enquire@iqpc.co.uk Visit: http://www.clinicalsupplyeurope.com

×